Matinas Biopharma (NYSE: MNTB) Trade Summary Ticker: MTNB (Last: $1.57)Market Cap: $243MAccumulate: $1.50-1.60Price Target: $2.50-3.50Timeframe: 0-12 weeks Trade … [Read more...] about Why Buy MTNB?
Articles
MTNB Buy Alert
MTNB buy $1.53-1.60 Institutional investors are loading up following the JPM conference this week.PT= $2.50FYI I (Sultan) sold 1/4 of my position in LJPCLets's get this bread … [Read more...] about MTNB Buy Alert
Big Week for Bio: JP Morgan Healthcare Conference
Monday morning kicks off one of the largest biotech events of the year: the JP Morgan Healthcare Conference. This conference is a four day event of the "who's who" in the world of biotech. Here, … [Read more...] about Big Week for Bio: JP Morgan Healthcare Conference
Seattle Genetics: Initial Expectations for Enfortumab Vedotin
I previously posed an investment thesis for Seattle Genetics (SGEN) published here at MS Money Moves on May 24th, when the share price was $69.11. Seattle Genetics closed trading on December 24th at … [Read more...] about Seattle Genetics: Initial Expectations for Enfortumab Vedotin
NGM BTFD!
(BTFD = Buy The F$%#$ng Dip) NGM is down on low volume attributable to bold short sellers. The stock has not left its channel beginning in November 2019. In our view, shares are being offered … [Read more...] about NGM BTFD!
DelMar Pharmaceuticals (Nasdaq: DMPI) Bull Case is Reinforced by Positive Data Update
A few months ago, DelMar Pharmaceuticals (NASDAQ: DMPI) caught our attention as a mischaracterized turn-around story in the making. After digging I found that much of DelMar’s competition have failed … [Read more...] about DelMar Pharmaceuticals (Nasdaq: DMPI) Bull Case is Reinforced by Positive Data Update
